MOLN Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Molecular Partners AG - Alpha Spread

Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 4.67 USD -3.51%
Market Cap: 155m USD
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 8.76 USD with a low forecast of 3.6 USD and a high forecast of 18.69 USD.

Lowest
Price Target
3.6 USD
23% Downside
Average
Price Target
8.76 USD
87% Upside
Highest
Price Target
18.69 USD
300% Upside
Molecular Partners AG Competitors:
Price Targets
COV
Covalon Technologies Ltd
152% Upside
VRTX
Vertex Pharmaceuticals Inc
9% Upside
ASND
Ascendis Pharma A/S
29% Upside
RLAY
Relay Therapeutics Inc
178% Upside
084650
Labgenomics Co Ltd
65% Upside
DVYSR
Devyser Diagnostics AB
5% Upside
BIOA B
BioArctic AB
114% Upside
IMM
Immutep Ltd
192% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 38%.

-16%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
8.76 USD

According to Wall Street analysts, the average 1-year price target for MOLN is 8.76 USD with a low forecast of 3.6 USD and a high forecast of 18.69 USD.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
38%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 38%.

Back to Top